LAGUNA HILLS, CA--(Marketwired - July 21, 2016) - Itonis, Inc. (
Itonis is pleased to announce it received word from its Media Agency that the planned Ten Thousand (10,000) thirty (30) second commercial spots for its Emesyl® Nausea Relief product has begun.
The ad is being run in about 240 small cable television systems in over 40 states, and cumulatively makes up a network of approximately 1.0M homes. These runs are at various times day and night, and across all the networks on the platform.
"We've had several shareholder inquiries as to the status of our planned commercials. I can assure you we have been actively engaged with our Media Company pursuing this information on a daily basis. The response to our inquiries and the gathering of this information took a little longer than we expected; however, we're pleased that the ad campaign is finally underway," said Steve Pidliskey, Itonis Vice President.
The Emesyl commercial being run across the network platform can be viewed here: https://wrightmediagroup.com/?portfolio=emesyl-com
If you wish to download a standalone copy of the commercial please click here: http://www.itonisholdings.com/data/supporting_files/uploads/1578fee6c35342-emesyl_commercial.mov
If you wish to purchase Emesyl online please click here: http://www.emesyl.com/
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on the distribution of innovative products to the medical and pharmaceutical industries. The company also holds a licensing agreement with MyECheck Inc, which allows the company to use MyECheck's patented mobile payment application and share transaction revenue fees for point of purchase payments across various industries. Please visit www.itonisholdings.com for additional information.
Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
Image Available: http://www.marketwire.com/library/MwGo/2016/7/21/11G107530/Images/Tier1-5d69dfd1735ba382be218bdedd205a5d.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/7/21/11G107530/Images/map-7d3aea1a7c27ad16a7e1bef32227e5b0.jpg
Contact Information:
Contact:
Itonis, Inc.
Office@itonisholdings.com
